Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
reaction mass of Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[4-[bis(2- hydroxyethyl)amino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-, disodium salt and Benzenesulfonic acid, 5-[[4-[bis(2-hydroxyethyl)amino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-2-[2-[4-[[4-[(2-hydroxyethyl)amino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]-, disodium salt
EC number: 942-661-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- From July 13th to 27th, 2005
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study conducted according to internationally accepted testing guidelines and performed in compliance with Good Laboratory Practice. Justification for read across approach is given in the endpoint summary.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2005
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- adopted 24 April 2002
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 29 April 2004
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: RCC Ltd, CH·4414 Fiillinsdorf / Switzerland.
- Age at study initiation: 8 - 12 weeks (beginning of acclimatization). Nulliparous and non-pregnant.
- Weight at study initiation: 16 g - 24 g (ordered).
- Housing: individual accomodation in Makrolon type-2 cages with standard softwood bedding ("LignoceI", Schill AG, CH-4132 Muttenz).
- Diet : Pelleted standard Kliba 3433, batch no. 25/05 mouse maintenance diet (Provimi Kliba AG, CH-4303 Kaiseraugst) available ad Iibitum.
- Water: community tap water from ltingen, available ad Iibitum.
- Acclimation period: under test conditions after health examination. Only animals without any visible signs of illness were used for the study.
ENVIRONMENTAL CONDITIONS
- Temperature: ranges for room temperature 22 ± 3 °C.
- Humidity: 30 - 70 %.
- Air changes: 10 - 15 air changes per hour.
- Photoperiod: 12 hour fluorescent light / 12 hour dark cycle.
- Other: at least 8 hours music during the light period.
Room temperature and humidity were monitored continuously and values outside of these ranges occasionally occurred, usually following room cleaning. These transient variations are considered not to have any influence on the study and, therefore, these data are not reported but are retained at testing laboratory.
Study design: in vivo (LLNA)
- Vehicle:
- other: ethanol/water (7/3, v/v)
- Concentration:
- 5 %, 10 % and 25 % (w/v) in ethanol/water (7/3, v/v)
- No. of animals per dose:
- 2 females for the pre-test (non GLP)
16 females for the main study, 4 per group - Details on study design:
- RANGE FINDING TESTS
- GLP compliance: non-GLP conform pre-test.
- Test animals: two mice.
- Vehicle: the test item was tested in different vehicles, i.e. acetone/olive oil (4/1, v/v) and ethanol/water (7/3, v/v). A suitable vehicle ethanol/water (7/3, v/v) was selected and used in the main test.
- Concentration: 2.5 %, 5 %, 10 % and 25% were tested on one ear each.
- Compound solubility: 25 % was the highest technically applicable concentration in the chosen vehicle.
- Irritation: one day after a single topical application no irritation effects were observed at the tested concentrations.
MAIN STUDY
TEST ITEM FORMULATIONS PREPARATION
The test item was placed into a volumetric flask on a tared Mettler balance and the vehicle ethano/water (7/3, v/v) was quantitatively added. The weight/volume (w/v) dilutions were prepared individually using a magnetic stirrer as homogenizer.
Test item formulations were made freshly before each dosing occasion and no more than 4 hours prior to application to the ears. Homogeneity of the test item in the vehicle was maintained during treatment with the magnetic stirrer.
Concentrations were in terms of material as supplied.
TOPICAL APPLICATION
Each test group of mice was treated by topical (epidermal) application to the dorsal surface of each ear lobe (left and right) with the test item at concentrations of 5 %, 10 % and 25 % (w/v) in ethanol/water (7/3, v/v). The application volume, 25 µl, was spread over the entire dorsal surface (Ø ~ 8 mm) of each ear lobe once daily for three consecutive days. A further group of mice was treated with an equivalent volume of the relevant vehicle alone (control animals).
ADMINISTRATION OF 3H-METHYL THYMIDlNE
Five days after the first topical application all mice were administered 250 µl of 81.87 µCi/ml 3HTdR (equal to 20.5 µCi 3HTdR) by intravenous injection via a tail vein.
DETERMINATION OF INCORPORATED 3HTDR
Approximately five hours after treatment with 3HTdR all mice were euthanized by inhalation of CO2 (dry ice).
The draining lymph nodes were rapidly excised and pooled for each experimental group (8 nodes per group). Single cell suspensions (phosphate buffered saline) of pooled lymph node cells were prepared by gentle mechanical disaggregation through stainless steel gauze (200 µm mesh size). After washing twice with phosphate buffered saline (approx. 10 ml) the lymph node cells were resuspended in 5 % trichloroacetic acid (approx. 3 ml) and incubated at approximately +4 °C for at least 18 hours for precipitation of macromolecules. The precipitates were then resuspended in 5 % trichloroacetic acid (1 ml) and transferred to glass scintillation vials with 10 ml of ‘lrga-Safe Plus' scintillation liquid and thoroughly mixed.
The level of 3HTdR incorporation was then measured on a β-scintillation counter. Similarly, background 3HTdR levels were also measured in two 1ml-aliquots of 5 % trichloroacetic acid.
The β-scintillation counter expresses 3HTdR incorporation as the number of radioactive disintegrations per minute (dpm).
INTERPRETATION OF RAW DATA
The proliferative response of lymph node cells is expressed as the number of radioactive disintegrations per minute per lymph node (dpm/node) and as the ratio of 3HTdR incorporated into lymph node cells of test group relative to that recorded for control group (Stimulation Index) (S.l.). Before dpm/node values were determined, mean scintillation-background dpm was subtracted from test and control raw data.
A test item is regarded as a sensitizer in the LLNA if the following criteria are fulfilled:
- First, exposure to at least one concentration of the test item resulted in an incorporation of 3HTdR at least 3-fold or greater than that recorded in control mice, as indicated by the Stimulation Index (S.I.).
- Second, the data are compatible with a conventional dose response, although allowance must be made (especially at high topical concentrations) for either local
toxicity or immunological suppression.
OBSERVATIONS
In addition to the sensitizing reactions the following observations and data were recorded during the test and observation period:
Mortality/Viability once daily from acclimatization start to the termination of in-life phase.
Body weights on the test day 1 (prior to the 1st application) and on the test day 6.
Clinical signs (local / systemic) once daily on the day of animals delivery and from test day 1 (after the 155 application) to the termination of in-life phase. Especially the treatment sites were observed carefully. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- The mean values and standard deviations were calculated in the body weight tables.
Results and discussion
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: Test item at 5 % (w/v): 0.9 Test item at 10 % (w/v): 1.1 Test item at 25 % (w/v): 1.6
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: Test item at 5 % (w/v): 1437 Test item at 10 % (w/v): 1895 Test item at 25 % (w/v): 2584
Any other information on results incl. tables
Calculation of the EC 3 value was not performed because no test concentrations produced a Stimulation Index (S.I.) of 3 or higher.
Test item conc. % (w/v) | Measurement dpm | Calculation | Result | |||
dpm - Background* | N. of lymph nodes | dpm per lymph nodes** | S.I. | |||
-- | Background I | 9 | -- | -- | -- | -- |
-- | Background II | 5 | -- | -- | -- | -- |
-- | Control group | 1664 | 1657 | 8 | 207 | -- |
5 | Test group | 1437 | 1430 | 8 | 179 | 0.9 |
10 | Test group | 1895 | 1888 | 8 | 236 | 1.1 |
25 | Test group | 2584 | 2577 | 8 | 322 | 1.6 |
*The mean Background was calculated from the figures Background I and Background ll values.
** Since the lymph nodes of the animals of a dose group were pooled, dpm/node was determined by dividing the measured value by the number of lymph nodes pooled.
VIABILITY I MORTALITY
No deaths occurred during the study period.
CLINICAL SIGNS
No clinical signs were observed in any animals of the control group, Group 2 (5 %) or Group 3 (10 %). On the second application day, a slight ear erythema was observed at both dosing sites in all mice of Group 4 (25 %), persisting for a total of two days. After each topical application, some residues of test item were found at both dosing sites in all mice of Group 4 (25 %).
BODY WEIGHTS
The body weight of the animals, recorded prior to the first application and prior to necropsy, was within the range commonly recorded for animals of the strain and age.
RESULTS OF POSITIVE CONTROL
Vehicle: acetone/olive oil (4/1, v/v)
Test item conc. % (w/v) | Measurement dpm | Calculation | Result | |||
dpm - Background* | N. of lymph nodes | dpm per lymph nodes** | S.I. | |||
-- | Background I | 0 | -- | -- | -- | -- |
-- | Background II | 0 | -- | -- | -- | -- |
-- | Control group | 2257 | 2257 | 8 | 282 | -- |
5 | Test group | 5310 | 5310 | 8 | 664 | 2.4 |
10 | Test group | 8055 | 8055 | 8 | 1007 | 3.6 |
25 | Test group | 25351 | 25351 | 8 | 3169 | 11.2 |
*The mean Background was calculated from the figures Background I and Background ll values.
** Since the lymph nodes of the animals of a dose group were pooled, dpm/node was determined by dividing the measured value by the number of lymph nodes pooled.
Test item conc. % (w/v) | S.I. | |
Group 2 | 5 (a) | 2.4 (b) |
Group 3 | 10 (c) | 3.6 (d) |
EC3 = (a-c) [(3-d)/(b-d)] + c = 7.5 % (w/v) |
EC3 = Estimated concentration for a Stimulation Index (S.I.) of 3.
a,b,c,d = Co-ordinates of the two pair of data lying immediately above and below the S.I. value of 3 on the LLNA dose response plot.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information according to the CLP Regulation (EC 1272/2008) Criteria used for interpretation of results: EU
- Conclusions:
- The substance was found to be a non-sensitizer (S.I. = 1.6) when tested up to the highest applicable concentration of 25 % (w/v) in ethanol/water (7/3, v/v).
- Executive summary:
In order to study a possible contact allergenic potential of the test item, three groups each of four female mice were treated daily at concentrations of 5 %, 10 % and 25 % (w/v) in ethanol/water (7/3, v/v) by topical application to the dorsum of each ear lobe (left and right) for three consecutive days. 25 % (w/v) was the highest technically applicable concentration in the vehicle. A control group of four mice was treated with the vehicle ethanol/water (7/3, v/v) only. Five days after the first topical application the mice were injected intravenously into a tail vein with radio-labelled thymidine (3H-methyl thymidine). Approximately five hours after intravenous injection, the mice were sacrificed, the draining auricular lymph nodes excised and pooled per group. Single cell suspensions of lymph node cells were prepared from pooled lymph nodes which were subsequently washed and incubated with trichloroacetic acid overnight. The proliferative capacity of pooled lymph node cells was determined by the incorporation of SH-methyl thymidine measured in a B- scintillation counter. All treated animals survived the scheduled study period. No clinical signs were observed in any animals of the control group, Group 2 (5 %) or Group 3 (10 %). On the second application day, a slight ear erythema was observed at both dosing sites in all mice of Group 4 (25 %), persisting for a total of two days. After each topical application, some residues of test item were found at both dosing sites in all mice of Group 4 (25 %).
A test item is regarded as a sensitizer in the LLNA it the exposure to one or more test concentrations resulted in 3-fold or greater increase in incorporation of 3HTdFt compared with concurrent controls, as indicated by the Stimulation Index (S.I.).
In the study S.I. of 0.9, 1.1 and 1.6 were determined with the test item at concentrations of 5 %, 10 % and 25 % (w/v), respectively, in ethanol/water (7/3, v/v).
Conclusion
According to the CLP Regulation (EC 1272/208), a stimulation index of three or more is considered a positive response in the local lymph node assay and this positive response is considered suitable to classify a substance as skin sensitizer.
The substance showed a S.I. of 1.6 when tested up to the highest applicable concentration of 25 % (w/v) in ethanol/water (7/3, v/v).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)
Čeprav agencija ECHA veliko spletnega gradiva objavlja v vašem jeziku, je ta stran deloma še vedno v angleščini. Več informacij o večjezikovni praksi agencije.
Dobrodošli na spletišču agencije ECHA Vsebina na tej strani ni v celoti podprta z brskalnikom Internet Explorer 7 (in starejšimi različicami). Prosimo, nadgradite vaš brskalnik Internet Explorer na novejšo različico.
Ta stran uporablja piškotke za zagotavljanje najboljše možne uporabniške izkušnje na našem spletišču.
Preberite več o tem, kako uporabljamo piškotke.